156 related articles for article (PubMed ID: 36199040)
1. Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: An observational study.
Paladin I; Pranić SM
BMC Med Res Methodol; 2022 Oct; 22(1):262. PubMed ID: 36199040
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials on drug-drug interactions registered in ClinicalTrials.gov reported incongruent safety data in published articles: an observational study.
Jurić D; Pranić S; Tokalić R; Milat AM; Mudnić I; Pavličević I; Marušić A
J Clin Epidemiol; 2018 Dec; 104():35-45. PubMed ID: 30081071
[TBL] [Abstract][Full Text] [Related]
3. Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis.
Chen KY; Borglund EM; Postema EC; Dunn AG; Bourgeois FT
Clin Trials; 2022 Aug; 19(4):442-451. PubMed ID: 35482320
[TBL] [Abstract][Full Text] [Related]
4. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
5. Comparison of reporting phase III randomized controlled trials of antibiotic treatment for common bacterial infections in ClinicalTrials.gov and matched publications.
Shepshelovich D; Yelin D; Gafter-Gvili A; Goldman S; Avni T; Yahav D
Clin Microbiol Infect; 2018 Nov; 24(11):1211.e9-1211.e14. PubMed ID: 29454846
[TBL] [Abstract][Full Text] [Related]
6. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications.
Hartung DM; Zarin DA; Guise JM; McDonagh M; Paynter R; Helfand M
Ann Intern Med; 2014 Apr; 160(7):477-83. PubMed ID: 24687070
[TBL] [Abstract][Full Text] [Related]
7. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.
Riveros C; Dechartres A; Perrodeau E; Haneef R; Boutron I; Ravaud P
PLoS Med; 2013 Dec; 10(12):e1001566; discussion e1001566. PubMed ID: 24311990
[TBL] [Abstract][Full Text] [Related]
8. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles.
Tang E; Ravaud P; Riveros C; Perrodeau E; Dechartres A
BMC Med; 2015 Aug; 13():189. PubMed ID: 26269118
[TBL] [Abstract][Full Text] [Related]
10. Haphazard reporting of deaths in clinical trials: a review of cases of ClinicalTrials.gov records and matched publications-a cross-sectional study.
Earley A; Lau J; Uhlig K
BMJ Open; 2013 Jan; 3(1):. PubMed ID: 23335556
[TBL] [Abstract][Full Text] [Related]
11. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
Ross JS; Mulvey GK; Hines EM; Nissen SE; Krumholz HM
PLoS Med; 2009 Sep; 6(9):e1000144. PubMed ID: 19901971
[TBL] [Abstract][Full Text] [Related]
12. Reporting characteristics of nonsurgical periodontal therapy trials registered in ClinicalTrials.gov: an observational study.
Stazić P; Jurić D; Turić A; Šošić A; Marušić A; Roguljić M
J Comp Eff Res; 2023 Aug; 12(8):e230058. PubMed ID: 37418255
[No Abstract] [Full Text] [Related]
13. Completeness of intervention description in invasive cardiology trials: an observational study of
Lišnić V; Ashraf H; Viđak M; Marušić A
Front Med (Lausanne); 2023; 10():1276847. PubMed ID: 37881632
[TBL] [Abstract][Full Text] [Related]
14. Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?
Lv JW; Chen YP; Zhou GQ; Liu X; Guo Y; Mao YP; Ma J; Sun Y
J Natl Compr Canc Netw; 2017 Nov; 15(11):1363-1371. PubMed ID: 29118228
[No Abstract] [Full Text] [Related]
15. Reporting of harms in clinical trials of esketamine in depression: a systematic review.
Taillefer de Laportalière T; Jullien A; Yrondi A; Cestac P; Montastruc F
Psychol Med; 2023 Jul; 53(10):4305-4315. PubMed ID: 37185130
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study.
Jurić D; Bolić A; Pranić S; Marušić A
J Clin Epidemiol; 2020 Jan; 117():126-137. PubMed ID: 31654788
[TBL] [Abstract][Full Text] [Related]
17. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858
[TBL] [Abstract][Full Text] [Related]
18. Trial registration, publication rate and characteristics in the research field of otology: A cross-sectional study.
van Heteren JAA; van Beurden I; Peters JPM; Smit AL; Stegeman I
PLoS One; 2019; 14(7):e0219458. PubMed ID: 31291350
[TBL] [Abstract][Full Text] [Related]
19. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles.
Pranić S; Marušić A
J Clin Epidemiol; 2016 Feb; 70():26-37. PubMed ID: 26226103
[TBL] [Abstract][Full Text] [Related]
20. Adverse event reporting in publications compared with sponsor database for cancer clinical trials.
Scharf O; Colevas AD
J Clin Oncol; 2006 Aug; 24(24):3933-8. PubMed ID: 16921045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
